VIOLIN Logo
Vaxar Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Compare Vaccines

Found 53 verified vaccines or vaccine candidates. To compare vaccines, please check two or more vaccines and click "Compare".

Selection ASC Vaccine Name Pathogen Name Disease Name Licensed? VO ID
12MP Cancer Cancer Research
Ag NY-ESO-1 Cancer Cancer Clinical trial
Alpha Fetoprotein Plasmid DNA Vaccine Cancer Cancer Clinical trial
Ankara (MVA) and ALVAC(2) Cancer Cancer Research
Ankara (MVA) Vaccine Cancer Cancer Research
autologous dendritic cell vaccine (DCV) Cancer Cancer Clinical trial
autologous dendritic cells (DCs) Cancer Cancer Clinical trial
autologous monocyte-derived mature DCs pulsed with p53, survivin and telomerase-derived peptides Cancer Cancer Research
Bacillus Calmette-Guerin (BCG), C. parvum Cancer Cancer Research
Cancer Subunit GV1001 Protein Vaccine Cancer Cancer Clinical trial VO_0011507
Canvaxin Cancer Cancer Research
class I HLA-A*0201-restricted gp100209-2M peptide Cancer Cancer Research
Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen Cancer Cancer Research VO_0004428
CpG 7909/PF3512676 Cancer Cancer Research
DNP-modified autologous vaccine Cancer Cancer Research
electroloading of mature dendritic cells with melanoma whole tumor cell lysate Cancer Cancer Research
Flagrp170 Cancer Cancer Research
gp100 + Mart-1 + Mart-3 Vaccine Cancer Cancer Research
gp100 Vaccine Cancer Cancer Research
gp100:209-217(210M) peptide vaccine Cancer Cancer Clinical trial
GVAX Lung Cancer Vaccine Cancer Cancer Clinical trial
hapten dinitrophenyl Cancer Cancer Research
Hexapeptide melanoma vaccine Cancer Cancer Clinical trial
HSPPC-96 Cancer Cancer Research
human leukocyte antigen class I-modified peptides Cancer Cancer Research
HUVECs-OK432 vaccine Cancer Cancer Research
IFN/tremem Cancer Cancer Research
IMM-101 Cancer Cancer Research
Incomplete Freund's adjuvant (IFA) alone, or a melanoma vaccine in IFA Cancer Cancer Clinical trial
intralesional bacile Calmette-Guérin (BCG) Cancer Cancer Research
intralesional bacile Calmette-Guérin (BCG), DTIC, vincristine Cancer Cancer Research
Ipilimumab Cancer Cancer Research
ipilimumab, vemurafenib Cancer Cancer Research
L612 HuMAb Cancer Cancer Licensed
Large Multivalent Immunogen (LMI) vaccine Cancer Cancer Research
mAb PC61 and DC/tumor fusion Cancer Cancer Research
MAGE-A12:170-178 Cancer Cancer Research
MAGE-A3 + AS15 Cancer Cancer Clinical trial
MAGE-A3-genetically modified lymphocytes Cancer Cancer Clinical trial
MART-1 Cancer Cancer Research
Melan-A/Mart-1 Cancer Cancer Research
Melanoma DNA vaccine TA2M™ encoding tyrosinase peptides Cancer Cancer Research VO_0004431
Melanoma-specific Melan-A/Mart-1 peptide + virus-like nanoparticles Cancer Cancer Research
mRNA-electroporated dendritic cells encoding gp100 and tyrosinase as melanoma vaccine Cancer Cancer Research VO_0004614
pCR3.1-VS-HSP65-TP-GRP6-M2 Cancer Cancer Research VO_0004609
Recombinant NY-ESO-1 ISCOMATRIX Vaccine Cancer Cancer Clinical trial VO_0004254
Recombinant NY-ESO-1 Protein vaccine adjuvanted with Imiquimod Cancer Cancer Clinical trial VO_0004248
SRL172 Cancer Cancer Research VO_0004610
Synchotrope TA2M Cancer Cancer Research
TICE BCG Cancer Cancer Licensed VO_0000103
TLR-9/GM Cancer Cancer Research
TriMixDC-MEL Cancer Cancer Clinical trial
tyrosinase240–251S, 368-376D Cancer Cancer Research
Display Option